BioSpace News Archive

BioMidwest

IBM Watson Health Presents New Data Demonstrating Real-World Progress of AI in Oncology at 2019 ASCO Annual Meeting

IBM Watson Health and its partners unveiled 22 new scientific studies that demonstrate progress in providing clinical decision support for cancer care globally at the American Society for Clinical Oncology 2019 annual meeting.

May 31, 2019
·
5 min read
Mallinckrodt to Present at Raymond James Life Sciences and Medtech Conference

Mallinckrodt Pharmaceuticals, a global biopharmaceutical company, will present on Wednesday, June 19, 2019, at the Raymond James Life Sciences and MedTech Conference at the Lotte New York Palace, 455 Madison Ave, New York.

May 31, 2019
·
2 min read
Drug Development

Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Improved Overall Survival as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma at Final Analysis of Pivotal Phase 3 KEYNOTE-048 Trial

Survival Benefit Now Observed with KEYTRUDA in Combination with Chemotherapy in All Patient Populations (Regardless of PD-L1 Expression) and with KEYTRUDA Monotherapy in Patients Whose Tumors Expressed PD-L1 at CPS ≥1

May 31, 2019
·
37 min read
Business

Beam Therapeutics and Bio Palette Announce Exclusive License Agreements for Base Editing Technologies

Beam Therapeutics and Bio Palette announced an exclusive cross-license agreement around each companies’ base editing intellectual property.

May 31, 2019
·
3 min read